Received Aug 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4D333 | IM / LA |
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A3X2K | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y012865 | IM / RA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | X1C891M | SC / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y015990 | SC / RA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | UNK | U8369BA | IM / RA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3RE73 | IM / LA |
Patient received Proquad -MMRV at 18 years of age, which is not within acceptable age range for this combined vaccine. No physical adverse reactions noted or reported.
N/A
N/A
N/A
NKDA
RN spoke with via phone and reported event to advising MD for guidance on 8/11/25.